Foundation Fighting Blindness Announces Leadership Changes
ncarol.com/10178661

Jason Menzo named chief executive officer

Russell Kelley, PhD, MBA, appointed managing director of the RD Fund

Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company

COLUMBIA, Md., June 21, 2022 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, announced today the promotions of Jason Menzo to chief executive officer (CEO) of the Foundation and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective July 1, 2022. Ben Yerxa, PhD, who has served as CEO of the Foundation since 2017, will be transitioning to assume the permanent CEO position for Opus Genetics, the first spin-off company internally conceived and launched by the RD Fund to further the Foundation's mission.

More on ncarol.com

• Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
• Heritage at Manalapan Introduces Luxury Single-Family Homes with Exceptional Value in One of Monmouth County's Most Desirable Locations
• Achugogo: Tale of the Spring Chaser Wins Inaugural TCCF Prize at Mifa Pitches, the Industry Market of the Annecy International Animation Film Festival
• Everything Policy Launches Madison, an AI Tool That Makes Legislation Readable for Students and Citizens
• TOLI North America Implements Modest Price Increase, Absorbing Majority of Costs

---

Show All News | Disclaimer | Report Violation